Kerala Ayurveda Ltd
Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]
- Market Cap ₹ 367 Cr.
- Current Price ₹ 305
- High / Low ₹ 347 / 98.0
- Stock P/E
- Book Value ₹ 4.71
- Dividend Yield 0.00 %
- ROCE 2.28 %
- ROE -42.8 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 63.8 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -4.86%
- The company has delivered a poor sales growth of 9.67% over past five years.
- Company has a low return on equity of -34.6% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.1.35 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
34 | 31 | 35 | 39 | 46 | 50 | 59 | 59 | 77 | 62 | 80 | 93 | 101 | |
33 | 28 | 31 | 33 | 38 | 43 | 51 | 54 | 69 | 61 | 71 | 91 | 97 | |
Operating Profit | 1 | 3 | 4 | 6 | 8 | 7 | 8 | 5 | 7 | 1 | 10 | 3 | 4 |
OPM % | 2% | 9% | 11% | 15% | 16% | 14% | 14% | 9% | 10% | 1% | 12% | 3% | 4% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 3 | 1 | |
Interest | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 3 | 2 | 6 | 7 | 5 | 4 |
Depreciation | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit before tax | -2 | 0 | 2 | 3 | 4 | 4 | 4 | 3 | 5 | -7 | 3 | -1 | -0 |
Tax % | -9% | 412% | 48% | 21% | 33% | 22% | 31% | 19% | 11% | 28% | 15% | 23% | |
-2 | -0 | 1 | 3 | 3 | 3 | 3 | 3 | 4 | -5 | 2 | -0 | -1 | |
EPS in Rs | -2.03 | -0.58 | 0.70 | 2.24 | 2.56 | 2.90 | 2.66 | 2.31 | 3.69 | -4.59 | 2.24 | -0.85 | -0.94 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 10% |
3 Years: | 7% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 65% |
Stock Price CAGR | |
---|---|
10 Years: | 29% |
5 Years: | 36% |
3 Years: | 76% |
1 Year: | 194% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -1% |
3 Years: | -35% |
Last Year: | -43% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
Reserves | -21 | -22 | -21 | -19 | -17 | -4 | -3 | -7 | -3 | -7 | -4 | -5 | -5 |
52 | 64 | 66 | 70 | 69 | 56 | 75 | 62 | 64 | 77 | 70 | 72 | 74 | |
9 | 10 | 11 | 11 | 11 | 17 | 20 | 27 | 31 | 34 | 34 | 37 | 40 | |
Total Liabilities | 50 | 63 | 66 | 73 | 73 | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 119 |
32 | 34 | 35 | 33 | 34 | 34 | 32 | 33 | 33 | 33 | 44 | 46 | 46 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 6 | 11 | 12 | 14 | 14 | 4 | 7 | 7 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
17 | 29 | 32 | 40 | 39 | 41 | 59 | 47 | 56 | 68 | 62 | 61 | 66 | |
Total Assets | 50 | 63 | 66 | 73 | 73 | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 119 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | -8 | -0 | 0 | 6 | 4 | -10 | 12 | 5 | 7 | -0 | 10 | |
-1 | -4 | -1 | -0 | -3 | -3 | -3 | -3 | -4 | -1 | -2 | -7 | |
-11 | 11 | 1 | 2 | -2 | 0 | 17 | -12 | 1 | 6 | -13 | -2 | |
Net Cash Flow | -3 | -0 | -1 | 2 | -0 | 1 | 4 | -2 | 2 | 12 | -16 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 28 | 47 | 36 | 35 | 33 | 35 | 34 | 43 | 51 | 61 | 61 | 51 |
Inventory Days | 125 | 223 | 413 | 287 | 227 | 319 | 338 | 311 | 313 | 268 | 254 | 227 |
Days Payable | 72 | 160 | 245 | 150 | 100 | 112 | 125 | 117 | 162 | 149 | 168 | 137 |
Cash Conversion Cycle | 80 | 110 | 204 | 172 | 160 | 242 | 247 | 236 | 202 | 179 | 147 | 141 |
Working Capital Days | 6 | -0 | 5 | 19 | 26 | 49 | 138 | 50 | 37 | 8 | 30 | 5 |
ROCE % | -3% | 2% | 5% | 8% | 9% | 9% | 9% | 6% | 9% | -0% | 11% | 2% |
Documents
Announcements
- Announcement Under Regulation 30 11h
-
Clarification sought from Kerala Ayurveda Ltd
19h - Exchange has sought clarification from Kerala Ayurveda Ltd on April 24, 2024 with reference to significant movement in price, in order to ensure that investors …
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 2d
- Certificate Under Regulation 40(9) 17 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Concalls
-
Nov 2018TranscriptNotesPPT
Business Overview:[1]
Company manufactures Ayurveda products and deals in Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs, and maintaining a herbarium of medicinal plants